PLSE begins patient enrollment in NANOPULSE-AF pivotal study, advancing its NPS tech toward potential AF treatment approval ...

Heart failure is common in people who have atrial fibrillation detected during screening, according to a presentation today at EHRA 2026 the annual congress of the European Heart Rhythm Association ...

Physicians wrestled with endpoint composition, low event rates, a possible difference in ischemic strokes, and more.

CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative.

Study suggests a path forward for device therapy, though caveats are plenty ...

CHAMPION-AF shows Boston Scientific's Watchman FLX as a safe, effective first-line option for stroke risk reduction in ...

MADRID, Spain—Stopping oral anticoagulation (OAC) improves outcomes among patients who remain free from atrial arrhythmia recurrences for at least a year after catheter ablation for atrial ...